IFNA1 and hepatocellular carcinoma: Furthermore, we showed that the β-catenin protein levels of the cells treated by DAA were higher than those of the cells treated by IFN (Figure 5A,D), which can be used to explain why patients treated with DAA had an apparent increased risk of HCC development when compared with patients treated with IFN [28,34,55].